The Michelson Prizes: Next Generation Grants are $150,000 research grants given annually to support promising researchers who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery and immunotherapy research for major global diseases.
Our committee is currently reviewing all applications for the Michelson Prizes: Next Generation Grants. The winners of the $150,000 research grants will be announced in December 2021.
The 2021 Michelson Prizes are looking for research proposals in two areas:
For both areas, the committee is looking for research that is highly innovative and impactful, with the potential to be applied across many diseases.
The Michelson Prizes & Grants in Human Immunology are supported by the Michelson Philanthropies and include two funding opportunities:
A rigorous and competitive international search will identify the most innovative projects from young scientists working across a broad range of scientific fields. Proposals will be reviewed by a distinguished committee of internationally-recognized scientists. The review committee will be looking for research that challenges dogma, from researchers who clearly articulate a vision that demonstrates an ability to look beyond convention to make a lasting impact on vaccine and immunotherapy research. We encourage applications from the full spectrum of scientific disciplines related to immunology, vaccine, and immunotherapy research, including but not limited to:
Clinical Research
Biochemistry
Molecular Biology
Protein engineering
Computer science
AI/Machine Learning
Biophysics
Nanotechnology
Bioengineering
Microbiome
Environmental Health
Vector Biology
Register to be emailed when the application portal opens:
Ansuman Satpathy, M.D., Ph.D., Stanford University
The application portal for the 2021 Michelson Prizes closed on June 18, 2021.
Applicants must be 35 or younger at the time of pre-application submission. Early career independent investigators, postdoctoral fellows, clinical fellows (including residents and interns), and other researchers currently in training positions are eligible for these awards. Eligible applicants must be employed by, or affiliated with, an eligible organization. Examples of eligible organizations include academia, biotechnology companies, foundations, government and non-governmental organizations, and research institutes.
Questions? Contact michelsonprizes@humanvaccinesproject.org.
Dr. Gary K. Michelson is a Board Certified Orthopedic Spinal Surgeon, with more than 900 issued patents worldwide. His work has revolutionized the practice of spinal surgery, making such procedures less invasive, less traumatic, safer, faster, and more effective. Alya Michelson is an accomplished journalist, who has written in, and been published in four different languages.
The Michelson Philanthropies includes three foundations that the Michelsons founded and fund; the Michelson Medical Research Foundation, 20MM, and Michelson Found Animals.
The Michelson Prizes & Grants in Human Immunology recognize young scientists pursuing innovative research and connect them with other innovators in immunology through the Michelson Prizes alumni network and the extensive partner network of the Human Vaccines Project and AAAS/Science.
